VanEck Associates’s Zepp Health ZEPP Stock Holding History

VanEck Associates’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-223	Closed	-$11K	–	1039
2020 Q2	$11K	Buy	+223	New	+$10.3K	﹤0.01%	985

Other funds holding ZEPP

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CMG

Cavalry Management Group San Francisco, California $22.3M AUM 65.95% 1-Year Est. Return

VanEck Associates's ZEPP Position: Q3 2020 in Review

VanEck Associates sold out of Zepp Health (ZEPP) in Q3 2020, closing a stake of 223 shares — an estimated $11K sold.

VanEck Associates first reported a position in ZEPP in Q2 2020 and held it in 1 quarter. The position peaked at $11K in Q2 2020. 62 funds tracked by Wall St. Rank hold ZEPP as of Q3 2020.

VanEck Associates reported no remaining Zepp Health position as of Q3 2020 after selling out during the quarter.
VanEck Associates sold 223 Zepp Health shares in Q3 2020, an estimated $11K.
VanEck Associates first reported a position in Zepp Health in Q2 2020 and held it in 1 quarter.
VanEck Associates's Zepp Health position peaked at $11K in Q2 2020.
62 funds tracked by Wall St. Rank held Zepp Health as of Q3 2020.

Based on VanEck Associates's 13F filing for Q3 2020, filed 12 Nov 2020.